Mitochondrial Dynamics Pathway in Neurodegeneration

Migration, Crosslink

📖

Mitochondrial Dynamics Pathway in Neurodegeneration

active

wiki page Created: 2026-04-02T07:19:52 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-mitochondrial-dynamics-p

📖 Wiki Page

mechanism1458 wordssynced 2026-04-02

Mitochondrial Dynamics Pathway in Neurodegeneration

Overview

Mitochondrial dynamics refer to the continuous balance between mitochondrial fission (division) and fusion (joining), essential for maintaining mitochondrial morphology, distribution, and quality control. This dynamic process is critical for neuronal health, as neurons are highly energy-demanding cells with specialized axonal and dendritic compartments requiring efficient mitochondrial trafficking and distribution[@chan].

Dysregulation of mitochondrial dynamics is a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). The balance between fission and fusion determines mitochondrial morphology, which directly impacts cellular energetics, calcium homeostasis, reactive oxygen species (ROS) production, and the ability to clear damaged mitochondria through mitophagy[@burte].

Molecular Mechanism

Key Regulators

| Process | Key Proteins | Function |
|---------|-------------|----------|
| Fusion (OMM) | MFN1, MFN2 | Outer membrane fusion |
| Fusion (IMM) | OPA1 | Inner membrane fusion |
| Fission | DRP1, FIS1, MFF | Mitochondrial division |
| Quality Control | PINK1, Parkin | Mitophagy initiation |

The Fission and Fusion Cycle

Mitochondrial dynamics operate as a continuous cycle essential for mitochondrial health:

...

Mitochondrial Dynamics Pathway in Neurodegeneration

Overview

Mitochondrial dynamics refer to the continuous balance between mitochondrial fission (division) and fusion (joining), essential for maintaining mitochondrial morphology, distribution, and quality control. This dynamic process is critical for neuronal health, as neurons are highly energy-demanding cells with specialized axonal and dendritic compartments requiring efficient mitochondrial trafficking and distribution[@chan].

Dysregulation of mitochondrial dynamics is a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). The balance between fission and fusion determines mitochondrial morphology, which directly impacts cellular energetics, calcium homeostasis, reactive oxygen species (ROS) production, and the ability to clear damaged mitochondria through mitophagy[@burte].

Molecular Mechanism

Key Regulators

| Process | Key Proteins | Function |
|---------|-------------|----------|
| Fusion (OMM) | MFN1, MFN2 | Outer membrane fusion |
| Fusion (IMM) | OPA1 | Inner membrane fusion |
| Fission | DRP1, FIS1, MFF | Mitochondrial division |
| Quality Control | PINK1, Parkin | Mitophagy initiation |

The Fission and Fusion Cycle

Mitochondrial dynamics operate as a continuous cycle essential for mitochondrial health:

Fusion Process:

Mitofusins (MFN1, MFN2) mediate outer mitochondrial membrane (OMM) tethering

OPA1 mediates inner mitochondrial membrane (IMM) fusion

Matrix contents intermix, allowing complementation of proteins and DNA

Fusion enables mitochondrial DNA repair, protein exchange, and metabolic complementation

Fission Process:

DRP1 is recruited from cytosol to OMM via receptor proteins (FIS1, MFF)

Drp1 oligomerizes into ring-like structures around mitochondria

GTP hydrolysis drives constriction and division

Daughter mitochondria can be healthy or damaged

Quality Control:

Damaged mitochondria fail to fuse and are marked for removal

PINK1 stabilizes on damaged mitochondrial OMM

Parkin is recruited to ubiquitinate mitochondrial proteins

Autophagosomes engulf marked mitochondria (mitophagy)

Pathway Diagram

Mermaid diagram (expand to render)

Dynamic Regulation of Mitochondrial Proteins

Mitofusins (MFN1 and MFN2)

MFN1 and MFN2 are GTPases located on the OMM that mediate mitochondrial tethering and fusion[@mfn2]:

MFN1: Primarily fusion-competent, higher GTPase activity
MFN2: Additional roles in mitochondrial transport, ER-mitochondria contacts
MFN2 mutations cause Charcot-Marie-Tooth disease type 2A
Both downregulated in AD brain[@fusion_ad]

OPA1

OPA1 (Optic Atrophy 1) mediates IMM fusion and cristae maintenance[@opa1]:

Over 8 isoforms generated by alternative splicing
Proteolytic cleavage regulates fusion competence
Mutations cause autosomal dominant optic atrophy
Critical for mitochondrial DNA maintenance

DRP1

DRP1 (Dynamin-related protein 1) is the master executor of mitochondrial fission[@drp1_ad]:

Cytosolic protein recruited to mitochondria during fission
Multiple phosphorylation sites regulate activity (Ser616, Ser637)
Post-translational modifications: phosphorylation, sumoylation, ubiquitination
Elevated in AD and correlates with pathology severity

FIS1 and MFF

FIS1 and MFF serve as Drp1 receptors on the OMM[@fis1]:

MFF is the primary receptor in most tissues
FIS1 may have additional roles in peroxisome biogenesis
Both upregulated in neurodegeneration models

Mechanisms in Alzheimer's Disease

Drp1 Hyperactivity

DRP1 expression and activity are significantly elevated in AD neurons[@drp1_ad]:

Post-translational modifications increase Drp1 activity
Pathological tau directly interacts with Drp1, enhancing fission[@tau_drp]
Amyloid-beta upregulates Drp1 expression via oxidative stress

The hyperactive fission creates a vicious cycle:

Excessive fission produces small, fragmented mitochondria

Fragmented mitochondria cannot meet neuronal energy demands

Impaired mitochondrial transport affects synaptic function

Synaptic loss and cognitive decline result

Tau-Mediated Effects

Pathological tau drives mitochondrial dysfunction through multiple mechanisms[@tau_drp]:

Direct interaction with Drp1 enhances its GTPase activity
Tau accumulation disrupts mitochondrial transport along axons
Hyperphosphorylated tau reduces MFN2 expression
Mitochondrial cristae disruption precedes cognitive decline

Amyloid-Beta Toxicity

Aβ oligomers induce mitochondrial fragmentation through[@abeta_mito]:

Direct interaction with mitochondrial proteins
Oxidative stress leading to Drp1 activation
Calcium dysregulation affecting mitochondrial dynamics
Impaired mitochondrial biogenesis

Fusion Deficits

AD neurons show significantly reduced fusion capacity[@fusion_ad]:

MFN2 and OPA1 expression decreased
OPA1 processing altered, reducing fusion-competent isoforms
ER-mitochondria contacts disrupted

Mechanisms in Parkinson's Disease

PINK1/Parkin Pathway

PINK1 and Parkin are central to PD pathogenesis[@pickrell]:

PINK1: Kinase that accumulates on damaged mitochondria
Parkin: E3 ubiquitin ligase recruited by PINK1
Together, they initiate mitophagy for quality control
Autosomal recessive PD: Caused by loss-of-function mutations in either gene

The PINK1/Parkin pathway[@pink1_parkin]:

Mitochondrial damage (complex I inhibition, oxidative stress)

PINK1 stabilizes on OMM (unable to enter mitochondria)

Parkin recruited and activated

Ubiquitination of mitochondrial surface proteins

Autophagy receptor binding (p62, optineurin)

Autophagosome engulfment and lysosomal degradation

MFN2 Dysfunction

MFN2 mutations and dysregulation contribute to PD[@mfn2]:

MFN2 polymorphism associated with PD risk
PINK1 phosphorylates MFN2 to promote mitophagy
MFN2 downregulation impairs mitochondrial dynamics
Affects dopaminergic neuron survival specifically

Complex I Deficiency

PD neurons show prominent complex I deficiency:

Environmental toxins (MPTP, rotenone) inhibit complex I
Mitochondrial DNA mutations accumulate in SNc
PINK1/Parkin pathway tries to compensate but fails
Energy crisis leads to dopaminergic neuron loss

Mechanisms in ALS

C9orf72 Expansions

The C9orf72 hexanucleotide repeat expansion is the most common genetic cause of ALS[@c9orf72]:

Leads to toxic RNA foci and dipeptide repeat proteins
Disrupts mitochondrial dynamics proteins
Impairs mitochondrial transport in motor neurons
Reduces mitochondrial membrane potential

FUS and TDP-43

ALS-associated proteins affect mitochondrial function:

FUS mutations disrupt mitochondrial DNA maintenance
TDP-43 pathology affects mitochondrial dynamics genes
Reduced fusion proteins in ALS motor neurons

SOD1 Mutations

SOD1 mutations cause mitochondrial dysfunction:

Mutant SOD1 accumulates in mitochondria
Disrupts electron transport chain
Induces mitochondrial fragmentation
Triggers apoptotic pathways

Therapeutic Targets

DRP1 Inhibitors

| Compound | Mechanism | Stage |
|----------|-----------|-------|
| Mdivi-1 | Inhibits Drp1 GTPase activity | Preclinical[@mdivi] |
| Drp1 siRNA | Gene silencing | Research |
| Dynasore | Inhibits dynamin 1/2 (less specific) | Research |

Fusion Promoters

| Approach | Target | Status |
|----------|--------|--------|
| MFN1/2 overexpression | Fusion | Research |
| OPA1 modulators | IMM fusion | Preclinical |
| Natural compounds | Various | Research |

PINK1/Parkin Modulation

| Strategy | Approach | Status |
|----------|----------|--------|
| AAV-Parkin | Gene therapy | Clinical trials |
| PINK1 activators | Small molecules | Research |
| USP30 inhibitors | Enhance Parkin function | Preclinical |

Mitochondria-Targeted Antioxidants

| Compound | Target | Status |
|----------|--------|--------|
| MitoQ | CoQ10 analog | Clinical trials |
| MitoVitE | Vitamin E analog | Research |
| SS-31 (Bendavia) | Cardiolipin | Clinical trials |
| CoQ10 | ETC complex I | Clinical trials |

Research Evidence

Key Publications

[Reddy PH et al. Mitochondrial Dysfunction in Alzheimer Disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34275909/)

[Itoh K et al. Mitochondrial Dynamics in Neurodegenerative Disease (2013)](https://pubmed.ncbi.nlm.nih.gov/24295535/)

[Wang X et al. Drp1 Phosphorylation in Neurodegenerative Diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33453287/)

[Chan DC. Mitochondrial Dynamics and Neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)

[Pickrell AM et al. Roles of PINK1, Parkin in PD (2015)](https://pubmed.ncbi.nlm.nih.gov/25666868/)

[Burte F et al. Disturbed Mitochondrial Dynamics in Neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/25482526/)

Recent Research Updates (2024-2026)

[Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging (2024)](https://pubmed.ncbi.nlm.nih.gov/39684566/)

[Longitudinal autophagy profiling reveals sustained mitophagy throughout healthy aging (2024)](https://pubmed.ncbi.nlm.nih.gov/39367235/)

[Modulation of Mitochondrial Dynamics by the Angiotensin System in Dopaminergic Neurons (2024)](https://pubmed.ncbi.nlm.nih.gov/39500352/)

[SUMOylation modulates mitochondrial dynamics in rotenone model of PD (2024)](https://pubmed.ncbi.nlm.nih.gov/39260456/)

[Mitotherapy-Based Approaches towards α-Synucleinopathies (2024)](https://pubmed.ncbi.nlm.nih.gov/38940084/)

[Tau pathology drives mitochondrial dysfunction via Drp1 (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Amyloid-beta induces mitochondrial fragmentation via Drp1 (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

Biomarkers and Clinical Relevance

Diagnostic Biomarkers

| Biomarker | Source | Disease | Status |
|-----------|--------|---------|--------|
| Drp1 levels | Blood/CSF | AD, PD | Research |
| PINK1 levels | Blood | PD | Research |
| Mitochondrial DNA copies | Blood | ALS | Research |
| Mitophagy markers | CSF | PD | Research |

Therapeutic Monitoring

Drp1 phosphorylation state (Ser616) as pharmacodynamic marker
Mitochondrial morphology in patient-derived neurons
Mitophagy flux measurements

Clinical Trials

MitoQ: NCT03821895 (PD), NCT03444220 (AD)
CoQ10: NCT00740753 (PD), NCT02655312 (AD)
SS-31 (Bendavia): NCT02240966 (AD)
AAV-Parkin: Recruiting for PD (NCT02795888)

slug	mechanisms-mitochondrial-dynamics-pathway
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c1eea6ac4ee3
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-mitochondrial-dynamics-pathway'}
_schema_version	1

📗 Cite This Artifact

Mitochondrial Dynamics Pathway in Neurodegeneration

Mitochondrial Dynamics Pathway in Neurodegeneration

Overview

Molecular Mechanism

Key Regulators

The Fission and Fusion Cycle

Mitochondrial Dynamics Pathway in Neurodegeneration

Overview

Molecular Mechanism

Key Regulators

The Fission and Fusion Cycle

Pathway Diagram

Dynamic Regulation of Mitochondrial Proteins

Mitofusins (MFN1 and MFN2)

OPA1

DRP1

FIS1 and MFF

Mechanisms in Alzheimer's Disease

Drp1 Hyperactivity

Tau-Mediated Effects

Amyloid-Beta Toxicity

Fusion Deficits

Mechanisms in Parkinson's Disease

PINK1/Parkin Pathway

MFN2 Dysfunction

Complex I Deficiency

Mechanisms in ALS

C9orf72 Expansions

FUS and TDP-43

SOD1 Mutations

Therapeutic Targets

DRP1 Inhibitors

Fusion Promoters

PINK1/Parkin Modulation

Mitochondria-Targeted Antioxidants

Research Evidence

Key Publications

Recent Research Updates (2024-2026)

Biomarkers and Clinical Relevance

Diagnostic Biomarkers

Therapeutic Monitoring

Clinical Trials

See Also

💬 Discussion